introduction
Lung cancer is the leading cause of worldwide cancer deaths [1] . Smoking, the primary lung cancer risk factor, is linked to 80%-85% of female cases and 90% of male cases [2] . Studies have established that smokers have greatly increased lung cancer risk [3, 4] and that lung cancer incidence and mortality increase in a dose-dependent manner with smoking [4] [5] [6] . Smoking cessation reduces the risk of lung cancer incidence and mortality [3, 5, 7] . Among an estimated 16 000-24 000 lung cancer cases occurring annually in US never smokers (NS) [8] , women have higher incidence rates than men [9] .
Passive smoking is also an established risk factor for lung cancer [10] . However, evidence is mixed regarding which settings and durations of passive exposure are linked to increased lung cancer risk. Some studies report a positive association between lung cancer incidence and passive smoking during childhood [11, 12] , adulthood home [13] [14] [15] , and work [16, 17] , including dose-dependent relationships [14, 15, 18] ; other studies have found these correlations only at extensive exposure levels (≥40-80 pack-years) [19] [20] [21] [22] or not at all for certain exposure categories [6, 11, 20, 23] .
Despite extensive literature on smoking and lung cancer, few prospective cohort studies contain data on both active and passive smoking; most studies on this relationship in women have been conducted in case-control settings. Therefore, we studied relationships among active and passive smoking with lung cancer incidence using data from a large, multiethnic prospective cohort, the Women's Health Initiative Observational Study (WHI-OS). To our best knowledge, this is the first study to investigate the effect of both active and passive smoking on lung cancer risk in a complete prospective cohort of US women.
methods design, setting, and participants
The WHI-OS is a multiethnic prospective cohort study designed to study morbidity and mortality in postmenopausal women; the study design has been previously described [24] . In brief, 93 676 postmenopausal women aged 50-79 were enrolled between 1993 and 1998 at 40 US clinical centers. Excluded from the original cohort were 1351 women due to incomplete data on smoking and 16 021 due to missing covariate data, resulting in 76 304 women for the study analysis.
measurement of exposures and confounders
This study aimed to determine the relationship between active/passive smoking and lung cancer incidence. All information on exposures and confounders was collected at baseline. NS were defined by questionnaire as having smoked <100 cigarettes in their lifetime (N = 39 771: 36 135 with passive exposure, 3636 without). Former smokers (FS) were classified as having smoked ≥100 cigarettes but not smoking at study baseline (N = 31 804). Current smokers (CS) reported smoking at baseline (N = 4729). CS and FS also reported age at smoking initiation, cigarettes/day, years of smoking, and age at quitting smoking (FS only).
We classified women who had only passive smoking exposure (i.e. no history of active smoking) as 'passive smokers'. Passive smoking data were self-reported in three categories in our analysis: childhood (<18 years), adult home (lived with smoker), and work (worked with smoker). For positive categories, women also reported exposure duration (childhood: <1, 1-4, 5-9, 10-18 years; adult home/work: <1, 1-4, 5-9, 10-19, 20-29, 30-39, ≥40 years).
The multivariable model adjusted for the following confounders (defined a priori, including established and hypothesized risk factors for lung cancer): age at enrollment, BMI, ethnicity, lung cancer history, family history of cancer, education, supplemental/dietary vitamin D, occupation, hormone therapy use, oral contraceptive use, alcohol use, physical activity, and servings/day of fruit, vegetables, and red meat.
classification of cases (follow-up and ascertainment)
Cancer cases were initially self-reported in annual questionnaires administered through 2009, with 93%-96% completion rates. Physicians adjudicated lung cancer diagnoses through medical records review, according to guidelines from Surveillance Epidemiology and End Results (SEER). When available through pathology reports, tumors were histologically classified according to International Classification of Disease for Oncology, second edition. Cases were further classified into non-small-cell lung cancer [NSCLC, subtypes: adenocarcinoma, squamous cell carcinoma (SqCC), large cell, neuroendocrine, other, unspecified], small-cell lung cancer (SCLC), and Other (carcinoid), according to SEER, AJCC Cancer Staging Handbook, and WHO [25] . 
statistical analysis
The primary outcome of interest was time to development of lung cancer. We used Cox proportional hazards regression models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Times were defined from enrollment into the WHI-OS to date of lung cancer diagnosis, death, loss to follow-up, or administrative censoring date (14 August 2009), whichever occurred first. We fit two models, age-and multivariable-adjusted. Participants missing information on any covariates in the model were excluded. For lung cancer subtypes, we used multinomial logistic regression models to calculate incidence because time of diagnosis was not available for subtype data. Kaplan-Meier method was used to graphically present results on lung cancer event-free survival by smoking status.
For the active smoking analysis, we estimated HRs for lung cancer development using the reference group of all NS. A secondary analysis on packyears used 0-5 pack-years as the reference group and adjusted for age at smoking initiation. For the passive smoking analysis, we included only participants with no history of active smoking. We defined passive smoking categories a priori based on the methodology of Luo et al. [26] which investigated breast cancer incidence and active/passive smoking in the WHI-OS. Their predefined passive exposure categories included dichotomizing childhood exposure (<10 years, ≥10 years), adult home exposure (<20 years, ≥20 years), and work exposure (<10 years, ≥10 years). Due to literature suggesting dose-dependent associations between lung cancer incidence and passive smoking [14, 15, 18, 23] , we further expanded the adult home ≥20 years category (20-<30 years, ≥30 years) and work ≥10 years category (10-<20 years, ≥20 years) a priori. We examined lung cancer incidence in relation to these predefined categories, as well as combinations where multiple exposures were summed in an un-weighted manner. Luo et al. defined an 'extensive exposure' category within the triple exposure category as childhood ≥10 years + adult home ≥20 years + work ≥10 years, which we further expanded as described above. We calculated HRs and Global Wald tests within passive smoking categories. All statistical analyses were completed using SAS 9.3 (SAS Institute, Cary, NC), and were two-sided at the 0.05 significance level.
results
The baseline characteristics of study participants, stratified by smoking status, are presented in Table 1 . Among 76 304 women included in the study cohort, the vast majority had active and/ or passive smoking exposure [N = 3636 NS-no passive (4.8%), N = 36 135 NS-passive (47.4%), N = 31 804 FS (41.7%), N = 4729 CS (6.2%)]. Approximately 85% of the participants were Caucasian. CS were more likely to be younger and have less education, lower physical exercise levels, lower BMIs, higher alcohol intake, higher use of oral contraceptives, and lower vitamin D intake. Additional characteristics of the cohort are presented in supplementary Tables S1-S4, available at Annals of Oncology online. There were not enough cases in each ethnic group to formally analyze incidence among NS.
The overall annualized lung cancer incidence rate was 112.3/ 100 000 person-years (CS 472.9, FS 158.1, NS 36.2, Table 2 ). When compared with NS, both CS (HR 13.44, 95% CI 10.80-16.75, P < 0.0001; multivariable-adjusted) and FS (HR 4.20, 95% CI 3.48-5.08, P < 0.0001) were significantly more likely to develop lung cancer, with CS also having a significantly higher risk than FS. For both CS and FS, the risk of developing lung cancer increased with pack-years (HR 1.58 for each 5-pack-year category, 95% CI 1.50-1.65, P < 0.0001); interaction term between CS and FS for the impact of increasing pack-years on risk was not significant (P = 0.49). The increased risk did not plateau up to ≥35 pack-years. Among NS, lung cancer incidence did not differ between NS with passive exposure compared with NS without passive exposure (HR 0.88, 95% CI 0.52-1.49; Table 2 ), nor did it differ among predefined passive smoking subcategories (childhood, adult home, work, or combinations or durations of these passive exposures) compared with reference groups (NS without passive exposure, either overall or in a specific setting). However, borderline significant increased lung cancer risk was seen in NS with adult home exposure ≥30 years when compared with women with no adult home exposure (HR 1.61, 95% CI 1.00-2.58). In models exploring duration of childhood exposure, adult exposure, and exposure at work (Table 2) , no significant interactions were seen among passive smoking categories, though the interaction between adult home and work approached significance (multivariable-adjusted P = 0.06). Global Wald P-values showed no significant differences in hazard within passive exposure categories.
The event-free survival for different smoking categories is displayed in a Kaplan-Meier plot in Figure 1A and B. CS had lower event-free survival rates than both FS and NS, while FS had lower event-free survival rates when compared with NS, log-rank test of equality over smoking categories P < 0.001. The event-free survival for NS with and without passive exposure did not appear to differ ( Figure 1B ).
NSCLC incidence was 97.9 per 100 000 person-years, and SCLC incidence was 9.9 (Table 3) . Excluding unspecified cases, adenocarcinoma was the most common NSCLC subtype (incidence 55.0), followed by SqCC (14.8). CS were significantly more likely to develop NSCLC (OR 12.05, 95% CI 9.48-15.32) and particularly SCLC (OR 100.84, 95% CI 30.13-337.45) than NS (P < 0.0001); the same was true for FS, with lower ORs than CS. CS and FS had a higher rate of developing all NSCLC subtypes, when compared with NS (P < 0.0001), with the highest risk seen for SqCC and the lowest risk seen for adenocarcinoma.
discussion
Few prospective cohort studies contain data on passive smoking. To our knowledge, this is the first study to investigate the relationship between both active and passive smoking with lung cancer risk in a complete prospective cohort of US women. In this cohort of 76 304 postmenopausal women, we found a significant association between active smoking and lung cancer incidence, which was dose-dependent for both CS and FS. CS were over 13 times more likely to develop lung cancer compared with NS; FS were over 4 times more likely. Among NS, we did not find a significant association between any passive smoking and lung cancer incidence; however, adult home passive exposure ≥30 years was of borderline significance. Smoking increased risk of all lung cancer subtypes ( particularly SCLC and SqCC), and smoking cessation decreased lung cancer risk.
comparison with other studies
Studies have estimated that active smokers have 5-to 30-fold increase in lung cancer incidence compared with NS [3, 4] . Our study confirms these findings in a prospective cohort of [3, 5, 6 ]. This analysis also confirms a dose-dependent relationship for active smoking and lung cancer development [4, 5] . For both CS and FS, lung cancer risk increased with 5-year pack-year categories up to ≥35 pack-years, suggesting that the dose-dependent relationship of smoking and lung cancer development continues at high cumulative smoking levels, without plateauing. Our findings on active smoking and lung cancer subtypes are also consistent with literature [3, 6, 23, 27] . Smoking had the strongest relationship with SCLC and SqCC incidence, and the smallest with adenocarcinoma. Quitting smoking decreases risk of developing all lung cancer subtypes. We found large HRs and CIs for SCLC and SqCC among CS, which may have been due to small number of reference cases. We were unable to examine passive smoking and lung cancer subtypes due to sample size.
Among NS, we found that passive smokers (ever-exposed, as well as predefined categories including childhood, adult home, and work) were not at significantly increased lung cancer risk; however, several passive exposure categories, particularly adult home ≥30 years, had elevated point estimates and approached significance. Literature on passive smoking has been inconsistent with considerable heterogeneity of findings and many casecontrol studies, which are more susceptible to recall bias than cohort studies. While some publications have reported positive associations [11-14, 17, 27] , including dose-dependent relationships [13, 20, 27] , other studies have not found significant associations between lung cancer incidence and childhood passive smoking exposure [6, 19, 23, 28] , adult spouse/residential passive smoking [11, 28] , and workplace exposure [11, 18] . Additionally, some studies have found these associations only at extensive levels (40 or 80 pack-years in some cases) or exposure combinations [18] [19] [20] [21] [22] 28] .
There are several possible explanations as to why we did not find a clear association between overall passive smoking and lung cancer risk. There may be inaccuracies in self-report of passive exposures, which is likely most pronounced for childhood exposures. However, as exposure information was collected at baseline before lung cancer diagnosis, true recall bias is unlikely. The WHI-OS measured passive smoking exposure in 'years' rather than the more precise 'pack-years'; consequently, varying exposure levels may be combined into a single category. However, prospective studies containing passive smoking data are extremely rare, and self-report of passive smoking packyears may be impractical and inaccurate. The relatively small overall reference group (NS, no passive exposure) also resulted in wide CIs for some passive smoking categories, and sample size prevented further passive smoking segmentation.
We must also consider that passive smoking may have a weaker than expected association with lung cancer development for postmenopausal women, which some previous prospective cohort studies have suggested (see supplementary Table S5 , available at Annals of Oncology online, for comparison to prior prospective studies). Two large Japanese prospective studies with ∼38 000 total participants found excess but insignificant lung cancer risk from overall spousal passive smoking, which is similar to our result [18, 29] ; another large Japanese cohort study found significantly increased risk for wives of heavy smokers only [22] . The Nurses' Health Study also found insignificant associations for passive adult smoking exposure with lung cancer in US women, though few cases among NS were reported in the cohort [30] . Additionally, the American Cancer Society CPS-I/II cohort studies did not find a significant relationship between passive smoking and lung cancer mortality (both sexes) [31] . These results from prospective cohort studies are more conservative than many reviews and case-control studies [10, 13-17, 23, 27] . Though our results were not statistically significant, our findings suggest that high levels of passive smoking exposure may increase lung cancer risk, with adult home exposure possibly the greatest contributor. Further passive smoking research is warranted, particularly in a prospective cohort setting with pack-years measurement. Figure 1 . Event-free survival estimates with (A) number of subjects at risk, stratified by smoking status; and (B) number of subjects at risk, with further stratification of never smokers (passive/no passive exposure). Kaplan-Meier event-free survival plots are presented stratified by smoking status (current, former, neverno passive, and never-passive). Log-rank test of equality over smoking categories has P < 0.0001. When never smokers are further segmented, the hazards for never, no passive exposure and never, passive exposure cross over each other at several points and do not seem to be different from each other. collection of passive smoking exposure as 'years' rather than 'pack-years', and potential inaccuracies in self-reported data. Our analytic cohort also had a relatively small overall reference group (NS without passive exposure). We used baseline values for smoking status, as data were collected at study entry. However, as there were relatively few CS, exposure misclassification was likely minimal. Yearly WHI reassessments indicated that 99% of NS abstained from smoking, and ∼60% of CS continued smoking for 6 follow-up years. Lastly, the cohort was primarily Caucasian.
conclusions and policy recommendations
In conclusion, for a prospective cohort of US postmenopausal women, our study confirms literature findings that smoking increases the risk of all lung cancer subtypes. This relationship is dose-dependent with no plateau up to 35 pack-years. Smoking cessation decreases lung cancer risk. Our study did not find a significant relationship between overall passive smoking exposure and lung cancer among NS; however, adult home exposure ≥30 years was associated with borderline significant elevations in risk, suggesting that high levels of passive smoking may contribute to lung cancer risk. These passive smoking findings are intriguing and add to the controversy on this subject; more precise pack-years quantification of passive smoking in a prospective cohort setting is warranted. This study focused only on smoking and lung cancer; public policy must also consider that active and passive smoking have been established as strong contributors to morbidity and mortality associated with many health conditions, including cardiopulmonary disease, other cancers, and pregnancy complications and asthma in children [32] .
As lung cancer is the leading cause of US cancer deaths, our prospective study underscores the need for development and implementation of smoking prevention and cessation interventions for all ages, and for women as well as men. Additionally, given the high incidence and mortality of lung cancer with at least 10%-15% cases occurring NS in the United States [8, 9] , our results suggest that more research is needed on nonsmoking-related lung cancer risk factors, including but not limited to genetic, behavioral, hormonal, dietary, and environmental factors.
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